Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia
Abstract T cell prolymphocytic leukemia (T-PLL) is a rare disease with aggressive clinical course. Cytogenetic analysis, whole-exome and whole-genome sequencing have identified primary structural alterations in T-PLL, including inversion, translocation and copy number variation. Recurrent somatic mu...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/43304e766b734189afed60f90539ff6d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:43304e766b734189afed60f90539ff6d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:43304e766b734189afed60f90539ff6d2021-12-02T14:27:45ZEpigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia10.1038/s41598-021-87890-92045-2322https://doaj.org/article/43304e766b734189afed60f90539ff6d2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87890-9https://doaj.org/toc/2045-2322Abstract T cell prolymphocytic leukemia (T-PLL) is a rare disease with aggressive clinical course. Cytogenetic analysis, whole-exome and whole-genome sequencing have identified primary structural alterations in T-PLL, including inversion, translocation and copy number variation. Recurrent somatic mutations were also identified in genes encoding chromatin regulators and those in the JAK-STAT signaling pathway. Epigenetic alterations are the hallmark of many cancers. However, genome-wide epigenomic profiles have not been reported in T-PLL, limiting the mechanistic study of its carcinogenesis. We hypothesize epigenetic mechanisms also play a key role in T-PLL pathogenesis. To systematically test this hypothesis, we generated genome-wide maps of regulatory regions using H3K4me3 and H3K27ac ChIP-seq, as well as RNA-seq data in both T-PLL patients and healthy individuals. We found that genes down-regulated in T-PLL are mainly associated with defense response, immune system or adaptive immune response, while up-regulated genes are enriched in developmental process, as well as WNT signaling pathway with crucial roles in cell fate decision. In particular, our analysis revealed a global alteration of regulatory landscape in T-PLL, with differential peaks highly enriched for binding motifs of immune related transcription factors, supporting the epigenetic regulation of oncogenes and genes involved in DNA damage response and T-cell activation. Together, our work reveals a causal role of epigenetic dysregulation in T-PLL.Shulan TianHenan ZhangPan ZhangMichael KalmbachJeong-Heon LeeTamas OrdogPaul J. HampelTimothy G. CallThomas E. WitzigNeil E. KayEric W. KleeSusan L. SlagerHuihuang YanWei DingNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Shulan Tian Henan Zhang Pan Zhang Michael Kalmbach Jeong-Heon Lee Tamas Ordog Paul J. Hampel Timothy G. Call Thomas E. Witzig Neil E. Kay Eric W. Klee Susan L. Slager Huihuang Yan Wei Ding Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia |
description |
Abstract T cell prolymphocytic leukemia (T-PLL) is a rare disease with aggressive clinical course. Cytogenetic analysis, whole-exome and whole-genome sequencing have identified primary structural alterations in T-PLL, including inversion, translocation and copy number variation. Recurrent somatic mutations were also identified in genes encoding chromatin regulators and those in the JAK-STAT signaling pathway. Epigenetic alterations are the hallmark of many cancers. However, genome-wide epigenomic profiles have not been reported in T-PLL, limiting the mechanistic study of its carcinogenesis. We hypothesize epigenetic mechanisms also play a key role in T-PLL pathogenesis. To systematically test this hypothesis, we generated genome-wide maps of regulatory regions using H3K4me3 and H3K27ac ChIP-seq, as well as RNA-seq data in both T-PLL patients and healthy individuals. We found that genes down-regulated in T-PLL are mainly associated with defense response, immune system or adaptive immune response, while up-regulated genes are enriched in developmental process, as well as WNT signaling pathway with crucial roles in cell fate decision. In particular, our analysis revealed a global alteration of regulatory landscape in T-PLL, with differential peaks highly enriched for binding motifs of immune related transcription factors, supporting the epigenetic regulation of oncogenes and genes involved in DNA damage response and T-cell activation. Together, our work reveals a causal role of epigenetic dysregulation in T-PLL. |
format |
article |
author |
Shulan Tian Henan Zhang Pan Zhang Michael Kalmbach Jeong-Heon Lee Tamas Ordog Paul J. Hampel Timothy G. Call Thomas E. Witzig Neil E. Kay Eric W. Klee Susan L. Slager Huihuang Yan Wei Ding |
author_facet |
Shulan Tian Henan Zhang Pan Zhang Michael Kalmbach Jeong-Heon Lee Tamas Ordog Paul J. Hampel Timothy G. Call Thomas E. Witzig Neil E. Kay Eric W. Klee Susan L. Slager Huihuang Yan Wei Ding |
author_sort |
Shulan Tian |
title |
Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia |
title_short |
Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia |
title_full |
Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia |
title_fullStr |
Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia |
title_full_unstemmed |
Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia |
title_sort |
epigenetic alteration contributes to the transcriptional reprogramming in t-cell prolymphocytic leukemia |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/43304e766b734189afed60f90539ff6d |
work_keys_str_mv |
AT shulantian epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT henanzhang epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT panzhang epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT michaelkalmbach epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT jeongheonlee epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT tamasordog epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT pauljhampel epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT timothygcall epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT thomasewitzig epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT neilekay epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT ericwklee epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT susanlslager epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT huihuangyan epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia AT weiding epigeneticalterationcontributestothetranscriptionalreprogrammingintcellprolymphocyticleukemia |
_version_ |
1718391305797632000 |